163 related articles for article (PubMed ID: 23761964)
1. Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.
Lin T; Gong L; Sun XH; Zhao NQ; Chen W; Yuan HP; Shao Y; Gao MH; Tang H
Drug Des Devel Ther; 2013; 7():361-8. PubMed ID: 23761964
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.
Wang X; Wang L; Wu N; Ma X; Xu J
Chin Med J (Engl); 2015 Jan; 128(1):46-50. PubMed ID: 25563312
[TBL] [Abstract][Full Text] [Related]
3. [Clinical assessment of oral ganciclovir capsules on the treatment of herpes simplex keratitis].
Wang X; Xu JJ; LE QH; Wang Y; Wang WT
Zhonghua Yan Ke Za Zhi; 2010 Nov; 46(11):994-9. PubMed ID: 21211295
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
Kaufman HE; Haw WH
Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
[TBL] [Abstract][Full Text] [Related]
5. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers).
Croxtall JD
Drugs; 2011 Mar; 71(5):603-10. PubMed ID: 21443283
[TBL] [Abstract][Full Text] [Related]
7. Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?
Sahin A; Hamrah P
Ophthalmol Eye Dis; 2012; 4():23-34. PubMed ID: 23650455
[TBL] [Abstract][Full Text] [Related]
8. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK
J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
[TBL] [Abstract][Full Text] [Related]
9. Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy.
Castela N; Vermerie N; Chast F; Sauvageon-Martre H; Denis J; Godard V; Goldschmidt P; Pouliquen Y
J Ocul Pharmacol; 1994; 10(2):439-51. PubMed ID: 8083563
[TBL] [Abstract][Full Text] [Related]
10. Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
Colin J
Clin Ophthalmol; 2007 Dec; 1(4):441-53. PubMed ID: 19668521
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D
Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328
[TBL] [Abstract][Full Text] [Related]
12. Topical ganciclovir in the treatment of acute herpetic keratitis.
Tabbara KF; Al Balushi N
Clin Ophthalmol; 2010 Aug; 4():905-12. PubMed ID: 20823931
[TBL] [Abstract][Full Text] [Related]
13. Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis.
Wilhelmus KR; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Barron BA; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA;
Ophthalmology; 2020 Apr; 127(4S):S5-S18. PubMed ID: 32200827
[TBL] [Abstract][Full Text] [Related]
14. [The latest in herpes simplex keratitis therapy].
Labetoulle M
J Fr Ophtalmol; 2004 May; 27(5):547-57. PubMed ID: 15179314
[TBL] [Abstract][Full Text] [Related]
15. Management of herpes simplex virus epithelial keratitis.
Roozbahani M; Hammersmith KM
Curr Opin Ophthalmol; 2018 Jul; 29(4):360-364. PubMed ID: 29697435
[TBL] [Abstract][Full Text] [Related]
16. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
Carter SB; Cohen EJ
Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
[TBL] [Abstract][Full Text] [Related]
17. Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications.
Chou TY; Hong BY
Ther Clin Risk Manag; 2014; 10():665-81. PubMed ID: 25187721
[TBL] [Abstract][Full Text] [Related]
18. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.
Wu X; Chen X
Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113
[TBL] [Abstract][Full Text] [Related]
19. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.
Hoh HB; Hurley C; Claoue C; Viswalingham M; Easty DL; Goldschmidt P; Collum LM
Br J Ophthalmol; 1996 Feb; 80(2):140-3. PubMed ID: 8814744
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis.
Koizumi N; Miyazaki D; Inoue T; Ohtani F; Kandori-Inoue M; Inatomi T; Sotozono C; Nakagawa H; Horikiri T; Ueta M; Nakamura T; Inoue Y; Ohashi Y; Kinoshita S
Br J Ophthalmol; 2017 Feb; 101(2):114-119. PubMed ID: 27142389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
